Physician profile
Gregory J Deines
NPI 1427098532
$8,777.61
in general payments reported to CMS, 2019-2025
11 companies · $1,156 in 2025
The $1,156 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $5,315 · 2021: $136 · 2022: $459 · 2023: $884 · 2024: $615 · 2025: $1,156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,654.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $2,600.00 | 2020 | |
| Lilly USA, LLC | $2,600.00 | 2020 | |
| Medtronic, INC. | $1,992.06 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System, Abre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $479.34 | 2020-2024 | Jardiance |
| Sequel Med Tech, LLC | $272.28 | 2025 | Twiist |
| Medtronic Minimed, INC. | $233.43 | 2019-2020 | |
| Dexcom, INC. | $194.05 | 2023-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $166.17 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Beta Bionics, INC. | $137.86 | 2023 | Ilet Bionic Pancreas |
| Insulet Corporation | $80.50 | 2022 | |
| Abbott Laboratories | $21.92 | 2023 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Deines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.